Global Female Contraceptive Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

Global Female Contraceptive Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

The Global Female Contraceptive Market is expected to grow from USD 7,123.13 Million in 2018 to USD 10,569.46 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.79%.
The positioning of the Global Female Contraceptive Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Female Contraceptive Market including are Bayer AG, Cipla Limited, HLL Lifecare Limited, Mankind Pharma, Pfizer Inc., Allergan plc, Johnson & Johnson, Merck Sharp & Dohme Corp, Mithra Pharmaceuticals S.A., and Reckitt Benckiser Group plc.
On the basis of Contraceptive Drug, the Global Female Contraceptive Market is studied across Contraceptive Injections, Contraceptive Pills, Spermicides, and Topical Contraceptives.
On the basis of Contraceptive Devices, the Global Female Contraceptive Market is studied across Contraceptive Patches, Contraceptive Sponges, Diaphragms and Caps, Female Condoms, Intra Uterine Contraceptive Devices (IUCDs), Sub-dermal Contraceptive Implants, and Vaginal Rings.
On the basis of Distribution Channel, the Global Female Contraceptive Market is studied across Clinic, Hospital Pharmacy, Independent Pharmacy, and Online Platform.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Female Contraceptive Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Female Contraceptive Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Female Contraceptive Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Female Contraceptive Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Female Contraceptive Market

The report answers questions such as:

1. What is the market size of Female Contraceptive market in the Global?
2. What are the factors that affect the growth in the Global Female Contraceptive Market over the forecast period?
3. What is the competitive position in the Global Female Contraceptive Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Female Contraceptive Market?
5. What are the opportunities in the Global Female Contraceptive Market?
6. What are the modes of entering the Global Female Contraceptive Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
3. Executive Summary
3.1. Female Contraceptive Market: Outlook
3.2. Female Contraceptive Market: Current State & Forecast
4. Premium Insight
4.1. Market Connectivity
4.2. Market Data Feed
4.2.1. Market Sizing & Forecasting, by Contraceptive Drug
4.2.2. Market Sizing & Forecasting, by Contraceptive Devices
4.2.3. Market Sizing & Forecasting, by Distribution Channel
4.2.4. Market Sizing & Forecasting, by Geography
5. Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Challenges
6. Industry Insight
6.1. Porter’s Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Client Customizations
7. Global Female Contraceptive Market, by Contraceptive Drug
7.1. Contraceptive Injections
7.2. Contraceptive Pills
7.2.1. Hormonal Pills
7.2.2. Non-hormonal Pills
7.3. Spermicides
7.4. Topical Contraceptives
8. Global Female Contraceptive Market, by Contraceptive Devices
8.1. Contraceptive Patches
8.2. Contraceptive Sponges
8.3. Diaphragms and Caps
8.4. Female Condoms
8.5. Intra Uterine Contraceptive Devices (IUCDs)
8.6. Sub-dermal Contraceptive Implants
8.7. Vaginal Rings
9. Global Female Contraceptive Market, by Distribution Channel
9.1. Clinic
9.2. Hospital Pharmacy
9.3. Independent Pharmacy
9.4. Online Platform
10. Global Female Contraceptive Market, by Geography
10.1. Americas
10.1.1. Argentina
10.1.2. Brazil
10.1.3. Canada
10.1.4. Mexico
10.1.5. United States
10.2. Asia-Pacific
10.2.1. Australia
10.2.2. China
10.2.3. India
10.2.4. Japan
10.3. Europe, Middle East & Africa
10.3.1. France
10.3.2. Germany
10.3.3. Italy
10.3.4. Spain
10.3.5. United Kingdom
11. Competitive Landscape
11.1. 360iResearch FPNV Positioning Matrix
11.1.1. 360iResearch Quadrants
11.1.1.1. Forefront
11.1.1.2. Pathfinders
11.1.1.3. Niche
11.1.1.4. Vital
11.1.2. Business Strategy
11.1.2.1. Business Growth
11.1.2.2. Industry Coverage
11.1.2.3. Financial Viability
11.1.2.4. Channel Support
11.1.3. Product Satisfaction
11.1.3.1. Value for Money
11.1.3.2. Ease of Use
11.1.3.3. Product Features
11.1.3.4. Customer Support
11.2. Market Vendor Ranking Analysis
11.3. Competitive News Feed Analysis
12. Company Usability Profiles
12.1. Bayer AG
12.1.1. Overview
12.1.2. Strategy
12.1.3. SWOT
12.2. Cipla Limited
12.2.1. Overview
12.2.2. Strategy
12.2.3. SWOT
12.3. HLL Lifecare Limited
12.3.1. Overview
12.3.2. Strategy
12.3.3. SWOT
12.4. Mankind Pharma
12.4.1. Overview
12.4.2. Strategy
12.4.3. SWOT
12.5. Pfizer Inc.
12.5.1. Overview
12.5.2. Strategy
12.5.3. SWOT
12.6. Allergan plc
12.7. Johnson & Johnson
12.8. Merck Sharp & Dohme Corp
12.9. Mithra Pharmaceuticals S.A.
12.10. Reckitt Benckiser Group plc
13. Appendix
13.1. Discussion Guide
13.2. 360iResearch Competitive Strategic Window
13.2.1. Leverage Zone
13.2.2. Vantage Zone
13.2.3. Speculative Zone
13.2.4. Bottleneck Zone
13.3. Top Reports
13.3.1. Global Crane Rental Market
13.3.2. Global Computer Vision Market
13.3.3. Global Payment Gateway Market
13.3.4. Global B2B Travel Market
13.3.5. Global Varicose Vein Treatment Devices Market
13.4. Author Details

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook